Research Blogs

Read time: 2 minutes. Of the more than 234,000 people who will be diagnosed with lung cancer in 2025, roughly 50% are ineligible for lung cancer screening according to current

Read time: 3 minutes. As tobacco use has declined in recent years, we have seen a new demographic of lung cancer patients emerge. Lung cancer in individuals who have never smoked

Read time: 4 minutes. As a dedicated researcher and oncologist, Noura Choudhury, MD, at the University of Chicago, witnesses daily the urgent need for better treatments for lung

Read time: 3 minutes. When Erin Schenk, MD, PhD, began her journey as a junior faculty member at the University of Colorado, she treated patients with various types of lung cancer

Read time: 2 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts

Read time: 9 minutes. The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May

Read time: 2 minutes. When a person is treated for advanced-stage lung cancer, tumors will often shrink, and their symptoms may subside. An effective treatment will kill many tumor

Read time: 4 minutes. As the nation’s leading lung cancer nonprofit and member of the Cancer Grand Challenges Cachexia Team, LUNGevity has been working to improve our understanding

Read time: 3 minutes. Why did we build a tool to visualize data collected from patients and caregivers? Community members provide data but too often never see how their data was

Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts

Read time: 9 minutes. More than 22,000 cancer researchers from 81 countries got together for the annual American Association for Cancer Research (AACR) meeting in Chicago from

Read time: 8 minutes. Narjust Florez, MD, is the associate director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center